PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25225N0259Emergency purchase of oxervate — Dompe U.S. Inc

The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Apr 9, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

252-Network Contract Office 12 (36C252)

Awarding office

Dompe U.S. Inc

Recipient

Apr 9, 2025

PoP end

$159K

Obligated

$159K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Dompe U.S. Inc — $90

Contract facts

Federal

Contract number36C25225N0259

Also listed as36C252-25-N-0259

Also listed as36F79720D0017-36C25225N0259

Agency252-Network Contract Office 12 (36C252)

Awarding office252-Network Contract Office 12 (36C252)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentDompe U.S. Inc

CAGE89P46

UEIECCDSKQAN2J3

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79720D0017

Place of performanceSAN MATEO CA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startFeb 13, 2025

PoP end (current)Apr 9, 2025

Obligated$159K

Current value$159K

Potential value$159K

EMERGENCY PURCHASE OF OXERVATE (CENEGERMIN-BKBJ) 0.002% SOLUTION FOR PATIENT TREATMENT. is a federal award for 252-Network Contract Office 12 (36C252) held by Dompe U.S. Inc. Estimated value $159K ($159K obligated). Current period of performance ends Apr 9, 2025. Last award drew 1 bidder. Place of performance: SAN MATEO CA.

EMERGENCY PURCHASE OF OXERVATE (CENEGERMIN-BKBJ) 0.002% SOLUTION FOR PATIENT TREATMENT.

Recompete timing

Public

● Past PoP end (499 days ago)

Current PoP ended Apr 9, 2025 (499 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25225N0259?

36C25225N0259 (Emergency purchase of oxervate) is a 252-Network Contract Office 12 (36C252) award with a potential value of $159K, currently held by Dompe U.S. Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C252-25-N-0259?

36C252-25-N-0259 is the dashed form of PIID 36C25225N0259 (Emergency purchase of oxervate), held by Dompe U.S. Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25225N0259?

252-Network Contract Office 12 (36C252) awarded 36C25225N0259 to Dompe U.S. Inc (potential $159K).

Who is the incumbent on 36C25225N0259?

Dompe U.S. Inc is the incumbent. The current period of performance ends Apr 9, 2025.

When does Dompe U.S. Inc’s 36C25225N0259 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 9, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Feb 14, 2025 · refreshed monthly